Search

Quanterix Corp

Suletud

SektorTervishoid

3.24 1.89

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.16

Max

3.27

Põhinäitajad

By Trading Economics

Sissetulek

-31M

-49M

Müük

-3.5M

33M

Aktsiakasum

-0.45

Kasumimarginaal

-148.708

Töötajad

450

EBITDA

-38M

-49M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

-8.26% downside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

9. nov 2026

Turustatistika

By TradingEconomics

Turukapital

30M

144M

Eelmine avamishind

1.35

Eelmine sulgemishind

3.24

Uudiste sentiment

By Acuity

16%

84%

12 / 339 Pingereas Healthcare

Quanterix Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. sept 2026, 22:50 UTC

Quanterix Corp declined significantly in after-market trading, reversing a slight earlier gain, yet remains above its 20-day moving average and near its one-month range.

24. sept 2026, 20:07 UTC

Quanterix Corp's shares traded roughly flat, remaining near unchanged since Wednesday's close while positioned above its 20-day moving average.

18. sept 2026, 19:46 UTC

Quanterix Corp shares fell notably during Friday's trading session, with a significant decline around midday before partially recovering, remaining above the 20-day moving average.

17. sept 2026, 20:02 UTC

News

Quanterix Corp announced inducement grants totaling 625.64k restricted stock units, contributing to heightened investor interest as shares trade sharply higher.

16. sept 2026, 21:11 UTC

Quanterix Corp is advancing in after-market trading, reflecting a modest increase since Wednesday's close and maintaining a trend of three consecutive higher daily closes.

15. sept 2026, 20:01 UTC

Quanterix Corp shares are higher during Tuesday's session, maintaining positive momentum despite a broader market decline tied to the NY Empire State Manufacturing Index.

14. sept 2026, 20:03 UTC

News

Quanterix Corp appointed Dr. Yuri Fesko as Chief Medical Officer, yet shares are trading lower amid ongoing performance weakness.

11. sept 2026, 19:26 UTC

Quanterix Corp shares are higher amid market response to steady inflation data. Earlier, the stock pulled back from a session high before regaining momentum.

10. sept 2026, 20:07 UTC

Quanterix Corp shares are lower today, pressured by broader market conditions following the European Central Bank's interest rate hike.

9. sept 2026, 20:07 UTC

Quanterix Corp shares are lower today, reaching a session low amid ongoing weakness and trading near the lower end of their one-month range.

8. sept 2026, 20:07 UTC

Quanterix Corp shares are higher today, reflecting broader market dynamics amid speculation over a potential Federal Reserve interest rate hike.

4. sept 2026, 20:08 UTC

Quanterix Corp shares are higher today, continuing a strong upward trend since Thursday's close, despite broader market pressures from a strong jobs report.

3. sept 2026, 20:07 UTC

Quanterix Corp shares are lower today, continuing a decline since Wednesday. The stock is near the lower end of its one-month range.

2. sept 2026, 19:46 UTC

Quanterix Corp shares are higher today, though still below their 20-day moving average. Broader market conditions are affected by rising U.S. Treasury yields.

1. sept 2026, 20:01 UTC

Quanterix Corp shares are lower today, continuing a decline since Monday. Broader market concerns include rising oil prices and inflation expectations.

31. aug 2026, 19:16 UTC

Quanterix Corp shares are lower amid market anxiety following hawkish remarks from Federal Reserve Chair Kevin Warsh on potential interest rate hikes.

28. aug 2026, 23:41 UTC

Quanterix Corp shares are lower in after-market trading, following a decline earlier in the session amid rising U.S. Treasury yields and falling tech stocks.

24. aug 2026, 20:02 UTC

Quanterix Corp shares are lower today, continuing a decline that began Friday. The stock is near the lower end of its one-month range.

22. aug 2026, 00:02 UTC

Quanterix Corp shares are lower in after-market trading, continuing a decline since Friday's close, with no specific news identified for the movement.

20. aug 2026, 20:06 UTC

Quanterix Corp shares are higher today amid increased market activity. The stock's movement aligns with broader trends, including rising U.S. Treasury yields and crude oil prices.

19. aug 2026, 22:31 UTC

Quanterix Corp shares are higher in after-market trading, reflecting a broader equity rebound after the Treasury's announcement of increased buyback operations for longer-term debt.

18. aug 2026, 23:06 UTC

Quanterix Corp. shares are roughly flat in after-market hours. The stock remains near the lower end of its one-month range.

17. aug 2026, 20:01 UTC

News

Quanterix Corp shares are higher after Director William P. Donnelly's insider purchase of 72,245 shares at $2.93, despite a price target cut by Canaccord Genuity.

14. aug 2026, 23:01 UTC

Quanterix Corp shares are higher in after-market trading, despite no specific news. This follows mixed market sentiment after a decline in U.S. retail sales.

13. aug 2026, 20:02 UTC

Quanterix Corp shares are lower today amid a broader decline in the Life Sciences Tools & Services sub-sector, continuing a downward trend since Wednesday.

12. aug 2026, 23:01 UTC

Quanterix Corp. shares are trading roughly flat in after-market hours. The stock has seen a significant decline over the past month, remaining below its 20-day moving average.

11. aug 2026, 22:51 UTC

Quanterix Corp shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressure and rising crude oil prices.

10. aug 2026, 19:51 UTC

Event
Social Media
News

Quanterix Corp reported a wider second-quarter loss and lowered full-year revenue guidance, leading to a significant decline in shares amid investor concerns.

7. aug 2026, 19:16 UTC

Quanterix Corp shares are higher today, continuing a trend with three consecutive sessions of gains since Thursday. The stock is trading above its 20-day moving average.

5. aug 2026, 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

Võrdlus sarnastega

Hinnamuutus

Quanterix Corp Prognoos

Hinnasiht

By TipRanks

-8.26% langus

12 kuu keskmine prognoos

Keskmine 3 USD  -8.26%

Kõrge 3 USD

Madal 3 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Quanterix Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

2 ratings

0

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

12 / 339 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.